Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
06/2005
06/16/2005WO2004111192A3 Targeted delivery to legumain-expressing cells
06/16/2005WO2004108900A3 Plant transcriptional regulators of disease resistance
06/16/2005WO2004101742A3 Protease inhibitors for coronaviruses and sars-cov and the use thereof
06/16/2005WO2004099383A3 Chromatographic assay system
06/16/2005WO2004087877A3 Selected rna motifs to include cell death and/or apoptosis
06/16/2005WO2004081199A3 Novel compositions and methods for the treatment of immune related disease
06/16/2005WO2004065562A3 Endocan compositions and methods for the treatment of neoplasms
06/16/2005WO2004037195A3 Treatment of diabetes
06/16/2005WO2004031360A3 Therapeutic aptamers having binding specificity to gp41 of hiv
06/16/2005US20050132442 Expression vector comprising nucleotide sequences coding fungal fatty acid desaturase for use in generating transgenic organism with enhanced concentrations of alpha-linolenic acid
06/16/2005US20050132441 Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
06/16/2005US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
06/16/2005US20050130894 In sows and gilts by a single injection of a gonadotropin releasing hormone, a luteinizing hormone, and/or human chorionic gonadotropin, or derivatives or analogues to stimulate ovarian follicle ovulation; and breeding
06/16/2005US20050130307 Replication control region having the ability to convey a phenotype of altered plasmid copy number to the plasmid on which it resides
06/16/2005US20050130280 Fructose-bisphosphate aldolase regulatory sequences for gene expression in oleaginous yeast
06/16/2005US20050130131 Contacting macrophages in vitro with composition comprising hepatitis c viral particles, culture cells, incubate with non-macrophage cells, culture, recover viral particles; viricides and rational drug design
06/16/2005US20050130115 Method for altering the gender ratio of offspring in mammals by manipulation of spermatozoa
06/16/2005US20050129686 Use of NOTCH pathway interfering agents for treatment of plasma cell disorders
06/16/2005US20050127035 Addressable nanopores and micropores including methods for making and using same
06/16/2005CA2548208A1 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
06/16/2005CA2547668A1 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
06/16/2005CA2546017A1 Use of notch pathway interfering agents for treatment of plasma cell disorders
06/15/2005EP1541673A1 Novel probiotics for pet food applications
06/15/2005EP1540011A2 Method of detecting and quantifying hepatitis c virus
06/15/2005EP1539990A2 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE
06/15/2005EP1539807A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/15/2005EP1539790A2 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
06/15/2005EP1539221A2 Transferrin fusion protein libraries
06/15/2005EP1539188A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
06/15/2005EP1539157A2 Method of inhibiting choroidal neovascularization
06/15/2005EP1212420B1 Conditional immortalisation of cells
06/14/2005US6905831 Real time measurement of cellular responses
06/09/2005WO2005052134A2 Ttbks as modifiers of the beta catenin pathway and methods of use
06/09/2005WO2005052133A2 Method and markers for determining the genotype of horned/polled cattle
06/09/2005WO2005052132A2 Mbms as modifiers of branching morphogenesis and methods of use
06/09/2005WO2005052131A2 C140rf35 as modifier of the beta catenin pathway and methods of use
06/09/2005WO2005052130A2 Nrbps as modifiers of the rac pathway and methods of use
06/09/2005WO2005052129A2 Diptheria toxin variant
06/09/2005WO2005052128A2 Mrna transfected antigen presenting cells
06/09/2005WO2005052127A2 Real-time detection of nucleic acids and proteins
06/09/2005WO2005052126A2 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells
06/09/2005WO2005052125A2 24p3 receptors and uses thereof
06/09/2005WO2005052124A2 Modified dna cleaving enzymes and methods of use
06/09/2005WO2005052123A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
06/09/2005WO2005052122A2 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN
06/09/2005WO2005052121A2 Multivalent aptamers
06/09/2005WO2005052120A2 Apparatus and methods for assessing metabolic substrate utilization
06/09/2005WO2005052119A2 Adjuvants of immune response
06/09/2005WO2005052118A2 Method for identifying androgen receptor modulators with full or mixed agonist activity
06/09/2005WO2005052117A2 Improved methods of in vitro protein synthesis
06/09/2005WO2005052116A2 Preservative-containing virus formulations
06/09/2005WO2005051436A2 Method for tooth organ reconstruction
06/09/2005WO2005051320A2 Gcks as modifiers of branching morphogenesis and methods of use
06/09/2005WO2005051319A2 Plks as modifiers of the beta catenin pathway and methods of use
06/09/2005WO2005051314A2 Iraks as modifiers of branching morphogenesis and methods of use
06/09/2005WO2005033279A3 Discovery of novel soluble crystalline anesthetics
06/09/2005WO2005028630A3 Engineered zinc finger proteins for regulation of gene expression
06/09/2005WO2005028623A3 Broad host range pbbr1-based plasmid mutant derivatives having altered plasmid copy number
06/09/2005WO2005028616A9 Morphogen compositions and methods of use thereof to treat heart disorders
06/09/2005WO2005021728A3 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
06/09/2005WO2005017113A3 Metalloproteinase gene polymorphism in copd
06/09/2005WO2005010142A3 Plant centromere compositions
06/09/2005WO2005007812A3 Genes as diagnostic tools for autism
06/09/2005WO2005003314A3 A method of selecting an active oligonucleotide predictive model
06/09/2005WO2005003302A3 Novel methods to modulate mast cells
06/09/2005WO2005001034A3 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase
06/09/2005WO2004111195A3 Methods and use of zona-free therapeutic cloning
06/09/2005WO2004106496A3 Methods and compositions for use in homologous recombination in plant cells
06/09/2005WO2004104171A3 Ranbp2 as modifier of the pten/igf pathway and methods of use
06/09/2005WO2004104170A3 Tools for detecting moraxella catarrhalis.
06/09/2005WO2004101743A3 Three dimensional cell cultures in a microscale fluid handling system
06/09/2005WO2004092335A3 Photomodulation methods and devices for regulating cell proliferation and gene expression
06/09/2005WO2004081177A3 Intracellular signaling pathways in diabetic subjects
06/09/2005WO2004078932A3 Methods and systems for preparing virtual representations of molecules
06/09/2005WO2004072237A3 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine
06/09/2005US20050124791 Ion channel
06/09/2005US20050124067 For use in viral growth, identification, titering or manipulation; vaccine growth or manipulation; viral transduction of cells; or recombinant production, screening, or measurement of protein or protein interactions in vitro
06/09/2005US20050124010 Analyzing differences in molecular mass distinguishable by mass spectrographic analysis, fragmenting, separating via chromatography, then inputting to database; for producing transgenic microbes/plants having activatable traits
06/09/2005US20050123972 Such as ligand binding and screening assays and signalling assays; chimeric chemokine receptor can also form a component of a chemokine receptor modulator design program
06/09/2005US20050123952 Methods of rapid detection and identification of bioagents using microRNA
06/09/2005US20050123945 Identification of Novel Targets for Radio Sensitization Using a Genomic-Based Radiation Sensitivity Classifier
06/09/2005US20050123941 Expression vector comprising nucleotide sequences coding polypeptide associated with fructo-oligosaccharide proteins for use in prevention or treatment of infections, diarrheal, cell proliferative and immune system disorders
06/09/2005US20050123939 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
06/09/2005US20050123929 Allelic nucleotide sequences coding protease inhibitor for use as diagnostic tool in detection cows with enhanced milk production; multiple ovulation and embryo transfer
06/09/2005US20050123896 Drug screening a test agent, promoter silencing agents for treatment of cancer; histone deacetylase (HDAC) inhibitors like sodium butyrate and trichostatin A; modulate gene expression; bioassay, analysis; testing kits
06/09/2005US20050123571 Modulation of apoptosis
06/09/2005US20050123563 Lipoparticles comprising proteins, methods of making, and using the same
06/09/2005US20050123541 Anti-TNF antibodies, compositions, methods and uses
06/09/2005US20050123534 Humanised antibodies
06/09/2005CA2546771A1 Plks as modifiers of the beta catenin pathway and methods of use
06/09/2005CA2546747A1 Ttbks as modifiers of the beta catenin pathway and methods of use
06/09/2005CA2546420A1 Apparatus and methods for assessing metabolic substrate utilization
06/09/2005CA2546378A1 Mrna transfected antigen presenting cells
06/09/2005CA2541969A1 Real-time detection of nucleic acids and proteins
06/08/2005EP1537187A2 Organic species that facilitate charge transfer to or from nanostructures
06/08/2005EP1537138A2 Receptors and membrane-associated proteins
06/08/2005CN1624126A Ret ligand (retl) for stimulating neural and renal growth
06/07/2005US6902736 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
06/07/2005CA2222482C Non-virulent mycoplasma synoviae and vaccine thereof
06/02/2005WO2005049806A2 Novel nucleic acids and polypeptides
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 100